Logo image of APM

APTORUM GROUP LTD-CLASS A (APM) Stock Price, Quote, News and Overview

NASDAQ:APM - Nasdaq - KYG6096M1226 - Common Stock - Currency: USD

1.0951  -0.01 (-1.34%)

After market: 1.08 -0.02 (-1.38%)

APM Quote, Performance and Key Statistics

APTORUM GROUP LTD-CLASS A

NASDAQ:APM (2/21/2025, 8:01:27 PM)

After market: 1.08 -0.02 (-1.38%)

1.0951

-0.01 (-1.34%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High17.49
52 Week Low0.46
Market Cap7.82M
Shares7.14M
Float4.06M
Yearly DividendN/A
Dividend YieldN/A
PE54.76
Fwd PE0.02
Earnings (Next)04-28 2025-04-28/amc
IPO12-18 2018-12-18


APM short term performance overview.The bars show the price performance of APM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 40 -40 -60

APM long term performance overview.The bars show the price performance of APM in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of APM is 1.0951 USD. In the past month the price decreased by -11.33%. In the past year, price decreased by -34.82%.

APTORUM GROUP LTD-CLASS A / APM Daily stock chart

APM Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.97 357.10B
AMGN AMGEN INC 15.29 162.72B
GILD GILEAD SCIENCES INC 23.85 137.00B
VRTX VERTEX PHARMACEUTICALS INC 1669.79 124.40B
REGN REGENERON PHARMACEUTICALS 15.34 76.56B
ARGX ARGENX SE - ADR N/A 39.16B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 32.32B
BNTX BIONTECH SE-ADR N/A 28.77B
ONC BEIGENE LTD-ADR N/A 27.25B
NTRA NATERA INC N/A 21.43B
BIIB BIOGEN INC 8.54 20.49B
SMMT SUMMIT THERAPEUTICS INC N/A 16.31B

About APM

Company Profile

APM logo image Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. Its lead projects are ALS-4, SACT-1 and PathsDx Test. ALS-4 is a small drug molecule which appears to target the products produced by bacterial genes that facilitate the successful colonization and survival of the bacterium in the body or that cause damage to the body's systems. SACT-1 is the first repurposed drug candidate to be developed under the Smart-ACT drug discovery platform. The firm's pipeline is also enriched through the co-development of PathsDx Test, a novel molecular-based rapid pathogen identification and detection diagnostics technology, with Accelerate Technologies Pte Ltd, commercialization arm of the Singapore's Agency for Science, Technology and Research.

Company Info

APTORUM GROUP LTD-CLASS A

17 Hanover Square

London W1S 1BN GB

CEO: Ian Huen

Employees: 3

Company Website: http://www.aptorumgroup.com/

Investor Relations: http://ir.aptorumgroup.com

Phone: 442080929299

APTORUM GROUP LTD-CLASS A / APM FAQ

What is the stock price of APTORUM GROUP LTD-CLASS A today?

The current stock price of APM is 1.0951 USD. The price decreased by -1.34% in the last trading session.


What is the ticker symbol for APTORUM GROUP LTD-CLASS A stock?

The exchange symbol of APTORUM GROUP LTD-CLASS A is APM and it is listed on the Nasdaq exchange.


On which exchange is APM stock listed?

APM stock is listed on the Nasdaq exchange.


What is APTORUM GROUP LTD-CLASS A worth?

APTORUM GROUP LTD-CLASS A (APM) has a market capitalization of 7.82M USD. This makes APM a Nano Cap stock.


How many employees does APTORUM GROUP LTD-CLASS A have?

APTORUM GROUP LTD-CLASS A (APM) currently has 3 employees.


What are the support and resistance levels for APTORUM GROUP LTD-CLASS A (APM) stock?

APTORUM GROUP LTD-CLASS A (APM) has a support level at 1.09 and a resistance level at 1.43. Check the full technical report for a detailed analysis of APM support and resistance levels.


Is APTORUM GROUP LTD-CLASS A (APM) expected to grow?

The Revenue of APTORUM GROUP LTD-CLASS A (APM) is expected to grow by 9197.28% in the next year. Check the estimates tab for more information on the APM EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy APTORUM GROUP LTD-CLASS A (APM) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does APTORUM GROUP LTD-CLASS A (APM) stock pay dividends?

APM does not pay a dividend.


When does APTORUM GROUP LTD-CLASS A (APM) report earnings?

APTORUM GROUP LTD-CLASS A (APM) will report earnings on 2025-04-28, after the market close.


What is the Price/Earnings (PE) ratio of APTORUM GROUP LTD-CLASS A (APM)?

The PE ratio for APTORUM GROUP LTD-CLASS A (APM) is 54.76. This is based on the reported non-GAAP earnings per share of 0.02 and the current share price of 1.0951 USD. Check the full fundamental report for a full analysis of the valuation metrics for APM.


What is the Short Interest ratio of APTORUM GROUP LTD-CLASS A (APM) stock?

The outstanding short interest for APTORUM GROUP LTD-CLASS A (APM) is 2% of its float. Check the ownership tab for more information on the APM short interest.


APM Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to APM. When comparing the yearly performance of all stocks, APM turns out to be only a medium performer in the overall market: it outperformed 68.14% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

APM Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to APM. APM has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

APM Financial Highlights

Over the last trailing twelve months APM reported a non-GAAP Earnings per Share(EPS) of 0.02. The EPS increased by 100.48% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA 0.11%
ROE 0.08%
Debt/Equity 0.14
Chartmill High Growth Momentum
EPS Q2Q%65.26%
Sales Q2Q%-100%
EPS 1Y (TTM)100.48%
Revenue 1Y (TTM)-100%

APM Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to APM. The Buy consensus is the average rating of analysts ratings from 6 analysts.

For the next year, analysts expect an EPS growth of 86.79% and a revenue growth 9197.28% for APM


Ownership
Inst Owners0.89%
Ins OwnersN/A
Short Float %2%
Short Ratio0.03
Analysts
Analysts80
Price TargetN/A
EPS Next Y86.79%
Revenue Next Year9197.28%